SRC and glioblastoma: The detected kinases comprised relevant members involved in the aberrant signaling networks of glioblastoma, such as MAPKs, Src family, PKCs, CDKs, CAMK2s, and are here used to identify treatment specific response profiles to capture the MOA of the drugs.